Peripheral arterial thrombosis following administration of infliximab for Crohn disease
نویسندگان
چکیده
Infliximab is one of the most widely used tumour necrosis factor-alpha (TNF) inhibitors for control of Crohn disease. We report the case of a patient with ileocolonic Crohn disease developing major arterial thrombosis after treatment with infliximab. After conservative management and infliximab withdrawal, thrombus dissolution and vessel recannalisation were observed. Few cases of arterial thrombosis following infliximab treatment have been documented; continued vigilance in the reporting of adverse events of biological therapy is required given the development of newer biological agents.
منابع مشابه
Severe Acute Respiratory Distress Syndrome during Infliximab Therapy in a Patient with Crohn Disease
The occurrence of a noninfectious interstitial lung disease is a rare but life-threatening side effect of infliximab, an antitumor necrosis factor alpha antibody. The following case report of a patient with Crohn disease shows an extremely dramatic progression to a severe acute respiratory distress syndrome.
متن کاملAnticardiolipin Antibody in Patients with Behçet's Disease with and without Vascular Thrombosis
Objective: The clinical value of IgG anticardiolipin antibody in patients with Behçet's disease with or without vascular thrombosis was evaluated. Methods: IgG isotype of anticardiolipin (aCL) antibody was assessed in 40 Behçet's disease (BD) patients with venous or arterial thrombosis, 40 BD patients without venous or arterial thrombosis and 80 healthy subjects as controls. The levels of IgG...
متن کاملA case of posterior reversible encephalopathy syndrome in a child with Crohn's disease treated with Infliximab.
BACKGROUND AND AIMS Posterior reversible encephalopathy syndrome (PRES) is a clinico-radiological entity characterised by headache, seizures, visual disturbance, altered mental status and vasogenic oedema on neuro-imaging. We report a rare case of PRES in a 8-year-old female with Crohn's disease (CD) following Infliximab administration and colectomy. METHOD Clinical case reported including a ...
متن کاملGuillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy.
OBJECTIVE Diverse neurologic syndromes have been described in association with tumor necrosis factor alpha (TNFalpha) antagonist therapy for inflammatory arthritides and Crohn's disease. The objective of this study was to review the occurrence and clinical features of Guillain-Barré syndrome and its variant, the Miller Fisher syndrome, during TNFalpha antagonist therapy. METHODS The postmarke...
متن کاملSuccessful Treatment of Small Intestinal Bleeding in a Crohn's Patient with Noncirrhotic Portal Hypertension by Transjugular Portosystemic Shunt Placement and Infliximab Treatment
Small intestinal bleeding in Crohn's disease patients with noncirrhotic portal hypertension and partial portal and superior mesenteric vein thrombosis is a life-threatening event. Here, a case is reported in which treatment with azathioprine may have resulted in nodular regenerative hyperplasia, portal hypertension and portal vein thrombosis. The 56-year-old patient with Crohn's disease develop...
متن کامل